Contribution of CXCL12 secretion to invasion of breast cancer cells.
about
Therapeutic potential of chemokine signal inhibition for metastatic breast cancerc-Jun N-Terminal Kinases Mediate a Wide Range of Targets in the Metastatic CascadePreferential, enhanced breast cancer cell migration on biomimetic electrospun nanofiber 'cell highways'Exercise training in transgenic mice is associated with attenuation of early breast cancer growth in a dose-dependent mannerBlood vessel endothelium-directed tumor cell streaming in breast tumors requires the HGF/C-Met signaling pathway.Microfluidic source-sink model reveals effects of biophysically distinct CXCL12 isoforms in breast cancer chemotaxisThe Effects of Tamoxifen in Combination with Tranilast on CXCL12-CXCR4 Axis and Invasion in Breast Cancer Cell Lines.Tumour cell invasion: an emerging role for basal epithelial cell extrusion.Wnt/β-catenin pathway is required for epithelial to mesenchymal transition in CXCL12 over expressed breast cancer cellsMacrophage Densities Correlated with CXC Chemokine Receptor 4 Expression and Related with Poor Survival in Anaplastic Thyroid Cancer.Macrophage-dependent tumor cell transendothelial migration is mediated by Notch1/MenaINV-initiated invadopodium formation.Harnessing the immune system for the treatment of breast cancer.Pharmacological levels of Withaferin A (Withania somnifera) trigger clinically relevant anticancer effects specific to triple negative breast cancer cellsExpression of metastasis suppressor BRMS1 in breast cancer cells results in a marked delay in cellular adhesion to matrix.Downregulation of CXCL12 in mesenchymal stromal cells by TGFβ promotes breast cancer metastasis.Pubertal high fat diet: effects on mammary cancer development.Hypoxia in astrocytic tumors and implications for therapy.YKL-40/CHI3L1 drives inflammation on the road of tumor progression.Violacein inhibits matrix metalloproteinase mediated CXCR4 expression: potential anti-tumor effect in cancer invasion and metastasis.Molecular Pathways: Deciphering Mechanisms of Resistance to Macrophage-Targeted Therapies.Tumor-Associated Macrophages as Target for Antitumor Therapy.High salt induces anti-inflammatory MΦ2-like phenotype in peripheral macrophages.Neoadjuvant chemotherapy induces breast cancer metastasis through a TMEM-mediated mechanism.BRMS1 gene expression may be associated with clinico-pathological features of breast cancer.YKL-40 acts as an angiogenic factor to promote tumor angiogenesis.GPCR Signaling Mediates Tumor Metastasis via PI3KβMembrane Mucin Muc4 promotes blood cell association with tumor cells and mediates efficient metastasis in a mouse model of breast cancer.Tumor initiating cells induce Cxcr4-mediated infiltration of pro-tumoral macrophages into the brain.CXCL12-induced macropinocytosis modulates two distinct pathways to activate mTORC1 in macrophages.Loss of amphiregulin reduces myoepithelial cell coverage of mammary ducts and alters breast tumor growth
P2860
Q26798116-6B25C2DA-EE0A-4799-B7E3-7362945D3179Q26998420-EB411ACC-0EA1-4F69-AE7D-D80998BA7EE5Q30599338-0197F803-40B5-4E67-AF3A-F59A5C3959A4Q31145811-3C74134C-4062-46C7-81E6-37BAEAF26551Q33665092-E604AE79-E60D-4DA3-A070-20F61C17E01CQ33668704-CDB5E7F3-A6AF-425A-A88D-AC4791D65B77Q34146185-287447C4-20E9-46B9-B5BA-B3551C5FC222Q34425577-AC18E274-42BA-4550-87DE-BECC09168512Q36375106-283642AE-FCF8-4B67-95C4-68C09D58E8C7Q37316047-4984DD44-3885-43AC-873A-E41D24EA2279Q37454737-6E16C447-2844-4423-8E9F-6AADAF36870AQ37476039-D0361A14-ED2B-42FA-9039-42DA4866F2ADQ37548974-A4608E20-6005-4047-8BE6-BB34485E2B33Q37610995-126BD3A4-F77E-41E1-83C7-25A7574CBAB8Q37644078-6230CB97-51EF-459B-9FFA-CC80AB2E2E79Q37690070-0520F8C1-712A-4D7D-A08D-D77B2A0EDE3DQ38533276-906A1796-1702-4369-BC68-4A5743944027Q38574540-5A36D013-9CCD-4610-BFC2-746E866E4B85Q38934727-FFC947AD-FDB6-4F8F-8B73-AABA033CBDFAQ39022841-4A3AD614-68F9-445C-9C8C-7CA14B3D32D5Q39403895-D8969FD4-7F0C-4101-9DC8-3954D63D6BB6Q39732073-9CB11E92-A2DA-445F-B318-A1006A524564Q40134207-CF392478-0B8A-4525-AFF8-9A3E1758F935Q40202794-F46B5BC0-C6AD-4E04-A5AD-35BA2B5E5603Q41073254-5FAF9E6E-A92C-406C-A4C8-B61815374D9CQ42586240-3178E025-B928-4EFA-99B1-DEA0EE0D1742Q46214152-0652E477-895F-4A6F-83E2-9574FAEF9472Q49713433-795BEEC5-E9A3-4D4F-BE95-2AC34040540DQ51116329-32D151B6-4998-4D55-AB4A-26B3B4666DE2Q58113101-D4785D44-B468-4F74-8DBC-4A2B2E15EA03
P2860
Contribution of CXCL12 secretion to invasion of breast cancer cells.
description
2012 nî lūn-bûn
@nan
2012 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Contribution of CXCL12 secretion to invasion of breast cancer cells
@nl
Contribution of CXCL12 secretion to invasion of breast cancer cells.
@ast
Contribution of CXCL12 secretion to invasion of breast cancer cells.
@en
Contribution of CXCL12 secretion to invasion of breast cancer cells.
@en-gb
type
label
Contribution of CXCL12 secretion to invasion of breast cancer cells
@nl
Contribution of CXCL12 secretion to invasion of breast cancer cells.
@ast
Contribution of CXCL12 secretion to invasion of breast cancer cells.
@en
Contribution of CXCL12 secretion to invasion of breast cancer cells.
@en-gb
prefLabel
Contribution of CXCL12 secretion to invasion of breast cancer cells
@nl
Contribution of CXCL12 secretion to invasion of breast cancer cells.
@ast
Contribution of CXCL12 secretion to invasion of breast cancer cells.
@en
Contribution of CXCL12 secretion to invasion of breast cancer cells.
@en-gb
P2093
P2860
P3181
P356
P1476
Contribution of CXCL12 secretion to invasion of breast cancer cells
@en
P2093
Bin-Zhi Qian
Dianne Cox
E Richard Stanley
Haein Park
Jeffrey E Segall
Jeffrey W Pollard
Jeffrey Wyckoff
John Condeelis
Salvatore J Coniglio
Tatiana Smirnova
P2860
P2888
P3181
P356
10.1186/BCR3108
P407
P577
2012-02-07T00:00:00Z
P5875
P6179
1027710884